{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:42:12Z","timestamp":1794357732000,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100806"],"award-info":[{"award-number":["82100806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170775"],"award-info":[{"award-number":["82170775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270802"],"award-info":[{"award-number":["82270802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370765"],"award-info":[{"award-number":["82370765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042023kf0022"],"award-info":[{"award-number":["2042023kf0022"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epigenetic regulation is reported to play a significant role in the pathogenesis of various kidney diseases, including renal cell carcinoma, acute kidney injury, renal fibrosis, diabetic nephropathy, and lupus nephritis. However, the role of epigenetic regulation in calcium oxalate (CaOx) crystal deposition-induced kidney injury remains unclear. Our study demonstrated that the upregulation of enhancer of zeste homolog 2 (EZH2)-mediated ferroptosis facilitates CaOx-induced kidney injury. CaOx crystal deposition promoted ferroptosis in vivo and in vitro. Usage of liproxstatin-1 (Lip-1), a ferroptosis inhibitor, mitigated CaOx-induced kidney damage. Single-nucleus RNA-sequencing, RNA-sequencing, immunohistochemical and western blotting analyses revealed that EZH2 was upregulated in kidney stone patients, kidney stone mice, and oxalate-stimulated HK-2 cells. Experiments involving in vivo EZH2 knockout, in vitro EZH2 knockdown, and in vivo GSK-126 (an EZH2 inhibitor) treatment confirmed the protective effects of EZH2 inhibition on kidney injury and ferroptosis. Mechanistically, the results of RNA-sequencing and chromatin immunoprecipitation assays demonstrated that EZH2 regulates ferroptosis by suppressing solute carrier family 7, member 11 (SLC7A11) expression through trimethylation of histone H3 lysine 27 (H3K27me3) modification. Additionally, SOX4 regulated ferroptosis by directly modulating EZH2 expression. Thus, this study demonstrated that SOX4 facilitates ferroptosis in CaOx-induced kidney injury through EZH2\/H3K27me3-mediated suppression of SLC7A11.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12967-023-04793-1","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T09:02:47Z","timestamp":1704186167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["The SOX4\/EZH2\/SLC7A11 signaling axis mediates ferroptosis in calcium oxalate crystal deposition-induced kidney injury"],"prefix":"10.1186","volume":"22","author":[{"given":"Xinzhou","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhuo","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-6221","authenticated-orcid":false,"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"1","key":"4793_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bju.13828","volume":"120","author":"G Zeng","year":"2017","unstructured":"Zeng G, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017;120(1):109\u201316.","journal-title":"BJU Int"},{"issue":"1","key":"4793_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","volume":"62","author":"CJ Scales","year":"2012","unstructured":"Scales CJ, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160\u20135.","journal-title":"Eur Urol"},{"issue":"12","key":"4793_CR3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41581-020-0320-7","volume":"16","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon C, Krambeck AE, Rule AD. Determining the true burden of kidney stone disease. Nat Rev Nephrol. 2020;16(12):736\u201346.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"4793_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrneph.2017.10","volume":"13","author":"SR Mulay","year":"2017","unstructured":"Mulay SR, Anders H. Crystal nephropathies: mechanisms of crystal-induced kidney injury. Nat Rev Nephrol. 2017;13(4):226\u201340.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"4793_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.juro.2017.01.057","volume":"197","author":"LHR Xu","year":"2017","unstructured":"Xu LHR, et al. Temporal changes in kidney stone composition and in risk factors predisposing to stone formation. J Urol. 2017;197(6):1465\u201371.","journal-title":"J Urol"},{"issue":"2","key":"4793_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1442-2042.2007.01953.x","volume":"15","author":"M Tsujihata","year":"2008","unstructured":"Tsujihata M. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int J Urol. 2008;15(2):115\u201320.","journal-title":"Int J Urol"},{"key":"4793_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-3-319-51436-9_13","volume":"60","author":"AS Cruz-Solbes","year":"2017","unstructured":"Cruz-Solbes AS, Youker K. Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): role and implications in kidney fibrosis. Results Probl Cell Differ. 2017;60:345\u201372.","journal-title":"Results Probl Cell Differ"},{"issue":"12","key":"4793_CR8","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1111\/jcmm.17356","volume":"26","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. Research progress of endothelial\u2013mesenchymal transition in diabetic kidney disease. J Cell Mol Med. 2022;26(12):3313\u201322.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"4793_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"1","key":"4793_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):1.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"4793_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"6","key":"4793_CR12","doi-asserted-by":"publisher","first-page":"bio043182","DOI":"10.1242\/bio.043182","volume":"8","author":"HM Tang","year":"2019","unstructured":"Tang HM, Tang HL. Cell recovery by reversal of ferroptosis. Biol Open. 2019;8(6):bio043182.","journal-title":"Biol Open."},{"key":"4793_CR13","first-page":"1","volume":"2021","author":"J Wang","year":"2021","unstructured":"Wang J, et al. The cross-link between ferroptosis and kidney diseases. Oxid Med Cell Longev. 2021;2021:1\u201312.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"4793_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.nefro.2020.03.005","volume":"40","author":"D Martin-Sanchez","year":"2020","unstructured":"Martin-Sanchez D, et al. Ferroptosis and kidney disease. Nefrologia. 2020;40(4):384\u201394.","journal-title":"Nefrologia"},{"issue":"1","key":"4793_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3892\/ijmm.2020.4770","volume":"47","author":"Z He","year":"2021","unstructured":"He Z, et al. Role of ferroptosis induced by a high concentration of calcium oxalate in the formation and development of urolithiasis. Int J Mol Med. 2021;47(1):289\u2013301.","journal-title":"Int J Mol Med"},{"issue":"1","key":"4793_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1096\/fj.201901816R","volume":"34","author":"H Liu","year":"2020","unstructured":"Liu H, et al. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model. FASEB J. 2020;34(1):835\u201352.","journal-title":"FASEB J"},{"key":"4793_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","volume":"1253","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol. 2020;1253:3\u201355.","journal-title":"Adv Exp Med Biol"},{"key":"4793_CR18","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3389\/fphar.2019.01393","volume":"10","author":"C Yu","year":"2019","unstructured":"Yu C, Zhuang S. Histone methyltransferases as therapeutic targets for kidney diseases. Front Pharmacol. 2019;10:1393.","journal-title":"Front Pharmacol"},{"key":"4793_CR19","doi-asserted-by":"publisher","first-page":"640700","DOI":"10.3389\/fphys.2021.640700","volume":"12","author":"T Li","year":"2021","unstructured":"Li T, Yu C, Zhuang S. Histone methyltransferase EZH2: a potential therapeutic target for kidney diseases. Front Physiol. 2021;12:640700.","journal-title":"Front Physiol"},{"issue":"4","key":"4793_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41581-018-0103-6","volume":"15","author":"C Guo","year":"2019","unstructured":"Guo C, et al. Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications. Nat Rev Nephrol. 2019;15(4):220\u201339.","journal-title":"Nat Rev Nephrol"},{"issue":"Pt 1","key":"4793_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2019.08.027","volume":"67","author":"CS Moreno","year":"2020","unstructured":"Moreno CS. SOX4: The unappreciated oncogene. Semin Cancer Biol. 2020;67(Pt 1):57\u201364.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"4793_CR22","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ccr.2013.04.020","volume":"23","author":"N Tiwari","year":"2013","unstructured":"Tiwari N, et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23(6):768\u201383.","journal-title":"Cancer Cell"},{"issue":"1","key":"4793_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3892\/ijo.2015.3258","volume":"48","author":"S Hasegawa","year":"2016","unstructured":"Hasegawa S, et al. A crucial epithelial to mesenchymal transition regulator, Sox4\/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients. Int J Oncol. 2016;48(1):145\u201352.","journal-title":"Int J Oncol"},{"issue":"8","key":"4793_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1071\/RD13169","volume":"26","author":"X Huang","year":"2014","unstructured":"Huang X, et al. EZH2 is essential for development of mouse preimplantation embryos. Reprod Fertil Dev. 2014;26(8):1166.","journal-title":"Reprod Fertil Dev"},{"issue":"3","key":"4793_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/epigenomes6030023","volume":"6","author":"CH Loh","year":"2022","unstructured":"Loh CH, Veenstra GJC. The role of polycomb proteins in cell lineage commitment and embryonic development. Epigenomes. 2022;6(3):23.","journal-title":"Epigenomes"},{"issue":"6","key":"4793_CR26","doi-asserted-by":"publisher","first-page":"eaaw3593","DOI":"10.1126\/sciadv.aaw3593","volume":"5","author":"Y Sun","year":"2019","unstructured":"Sun Y, et al. Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease. Sci Adv. 2019;5(6):eaaw3593.","journal-title":"Sci Adv"},{"issue":"9","key":"4793_CR27","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1681\/ASN.2018010074","volume":"29","author":"Y Yang","year":"2018","unstructured":"Yang Y, et al. Interactions between macrophages and cyst-lining epithelial cells promote kidney cyst growth in Pkd1 -deficient mice. J Am Soc Nephrol. 2018;29(9):2310\u201325.","journal-title":"J Am Soc Nephrol"},{"key":"4793_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.774155","volume":"12","author":"Y Xia","year":"2021","unstructured":"Xia Y, et al. Construction and analysis of immune infiltration-related ceRNA network for kidney stones. Front Genetics. 2021;12: 774155.","journal-title":"Front Genetics"},{"key":"4793_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108677","volume":"107","author":"Z Ye","year":"2022","unstructured":"Ye Z, et al. CXCR4 inhibition attenuates calcium oxalate crystal deposition-induced renal fibrosis. Int Immunopharmacol. 2022;107: 108677.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"4793_CR30","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41419-021-04137-1","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, et al. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death Dis. 2021;12(9):843.","journal-title":"Cell Death Dis"},{"issue":"8","key":"4793_CR31","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.7150\/thno.53023","volume":"11","author":"L Yang","year":"2021","unstructured":"Yang L, et al. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression. Theranostics. 2021;11(8):3742\u201359.","journal-title":"Theranostics"},{"issue":"1","key":"4793_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13(1):1.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"4793_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00011-019-01221-3","volume":"68","author":"H Liang","year":"2019","unstructured":"Liang H, et al. EZH2 plays a crucial role in ischemia\/reperfusion-induced acute kidney injury by regulating p38 signaling. Inflamm Res. 2019;68(4):325\u201336.","journal-title":"Inflamm Res"},{"issue":"6","key":"4793_CR34","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.7150\/thno.83353","volume":"13","author":"B Li","year":"2023","unstructured":"Li B, et al. Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI. Theranostics. 2023;13(6):1860\u201375.","journal-title":"Theranostics"},{"issue":"5","key":"4793_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41419-019-1589-y","volume":"10","author":"J Ni","year":"2019","unstructured":"Ni J, et al. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression. Cell Death Dis. 2019;10(5):355.","journal-title":"Cell Death Dis"},{"issue":"3","key":"4793_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101725","volume":"298","author":"G Guan","year":"2022","unstructured":"Guan G, et al. TFPI2 suppresses the interaction of TGF-beta2 pathway regulators to promote endothelial\u2013mesenchymal transition in diabetic nephropathy. J Biol Chem. 2022;298(3): 101725.","journal-title":"J Biol Chem"},{"issue":"5","key":"4793_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.metabol.2015.01.014","volume":"64","author":"L Li","year":"2015","unstructured":"Li L, et al. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt\/beta-catenin signaling pathway in diabetic kidney disease. Metabolism. 2015;64(5):597\u2013610.","journal-title":"Metabolism"},{"issue":"1","key":"4793_CR38","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s41467-021-22617-y","volume":"12","author":"SP Srivastava","year":"2021","unstructured":"Srivastava SP, et al. Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy. Nat Commun. 2021;12(1):2368.","journal-title":"Nat Commun"},{"issue":"5","key":"4793_CR39","doi-asserted-by":"publisher","first-page":"102390","DOI":"10.1016\/j.isci.2021.102390","volume":"24","author":"SP Srivastava","year":"2021","unstructured":"Srivastava SP, et al. Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys. iScience. 2021;24(5):102390.","journal-title":"iScience"},{"issue":"6","key":"4793_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129034","volume":"5","author":"J Li","year":"2020","unstructured":"Li J, et al. Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules. JCI Insight. 2020;5(6): e129034.","journal-title":"JCI Insight"},{"issue":"6","key":"4793_CR41","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2337\/db13-1029","volume":"63","author":"K Kanasaki","year":"2014","unstructured":"Kanasaki K, et al. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen. Diabetes. 2014;63(6):2120\u201331.","journal-title":"Diabetes"},{"issue":"6","key":"4793_CR42","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1161\/HYPERTENSIONAHA.120.15587","volume":"76","author":"J Li","year":"2020","unstructured":"Li J, et al. Endothelial FGFR1 (fibroblast growth factor receptor 1) deficiency contributes differential fibrogenic effects in kidney and heart of diabetic mice. Hypertension. 2020;76(6):1935\u201344.","journal-title":"Hypertension"},{"issue":"2","key":"4793_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, et al. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325.","journal-title":"Cell Res"},{"issue":"1","key":"4793_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41419-020-2256-z","volume":"11","author":"Z Hu","year":"2020","unstructured":"Hu Z, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell Death Dis. 2020;11(1):73.","journal-title":"Cell Death Dis"},{"key":"4793_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jare.2020.07.007","volume":"28","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res. 2021;28:231\u201343.","journal-title":"J Adv Res"},{"issue":"1","key":"4793_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01157-x","volume":"19","author":"Y Wu","year":"2020","unstructured":"Wu Y, et al. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression. Mol Cancer. 2020;19(1):1.","journal-title":"Mol Cancer"},{"issue":"7","key":"4793_CR47","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847563","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. EMBO Rep. 2019;20(7): e47563.","journal-title":"EMBO Rep"},{"issue":"11","key":"4793_CR48","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41418-019-0304-y","volume":"26","author":"M Wang","year":"2019","unstructured":"Wang M, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26(11):2329\u201343.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4793_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-021-00762-2","volume":"28","author":"G Liu","year":"2021","unstructured":"Liu G, et al. HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression. J Biomed Sci. 2021;28(1):1.","journal-title":"J Biomed Sci"},{"issue":"12","key":"4793_CR50","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1681\/ASN.2020010052","volume":"31","author":"V Rudman-Melnick","year":"2020","unstructured":"Rudman-Melnick V, et al. Single-cell profiling of AKI in a murine model reveals novel transcriptional signatures, profibrotic phenotype, and epithelial-to-stromal crosstalk. J Am Soc Nephrol. 2020;31(12):2793\u2013814.","journal-title":"J Am Soc Nephrol"},{"key":"4793_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.semcancer.2019.06.022","volume":"67","author":"H Hanieh","year":"2020","unstructured":"Hanieh H, et al. SOX4: Epigenetic regulation and role in tumorigenesis. Semin Cancer Biol. 2020;67:91\u2013104.","journal-title":"Semin Cancer Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04793-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04793-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04793-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T21:03:17Z","timestamp":1704229397000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04793-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4793"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04793-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3170102\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Renmin Hospital Ethics Committee at Wuhan University gave its approval to this project\u00a0involving human participants (WDRY2021-KS047). The Laboratory Animal Welfare and Ethics Committee authorized all animal research (WDRM-20200604).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no competing interests regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}